Company intelligence / Profile preview

4Catalyzer

Guilford, Connecticut, United States

Ownership: Private
Employees: ~51
Development stage: Other

Overview

4Catalyzer is an incubator and accelerator, not a clinical-stage biotech company itself. Its portfolio companies have developed FDA-approved devices (e.g., portable MRI), commercialized full-body ultrasound on a chip, and advanced small molecule drugs to Phase 1 in cancer and rare diseases. It functions as an incubator and not as a standalone therapeutics or device company—it creates and launches startups that themselves commercialize health technologies, pharmaceuticals, diagnostics, and devices.

Modalities: DeviceSmall moleculeGene therapyBiologic
Industry: Investors

Beyond the preview

Go deeper on 4Catalyzer.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on 4Catalyzer.

Explore the full profile